The one-count felony charge filed on April 30, 2020 in the U.S. District Court in Fort Myers, Florida, charged FCS with participating in a criminal antitrust conspiracy with a competing oncology group in Collier, Lee, and Charlotte counties (“Southwest Florida”). The government charged that FCS and its co-conspirators agreed not to compete to provide chemotherapy and radiation treatments to cancer patients in Southwest Florida. Beginning as early as 1999 and continuing until at least 2016, FCS was alleged to have entered into an illegal agreement that allocated chemotherapy treatments to FCS and radiation treatments to a competing oncology group, which conspiracy allowed FCS to operate with minimal competition in Southwest Florida and limited valuable integrated care options and choices for cancer patients.
The U.S. Department of Justice’s Antitrust Division announced a deferred prosecution agreement (“DPA”) resolving the charge against FCS, under which FCS admitted to conspiring to allocate chemotherapy and radiation treatments for cancer patients. FCS has agreed to pay a $100 million criminal penalty (the statutory maximum) and to cooperate fully with the Antitrust Division’s ongoing investigation. FCS has also agreed to maintain an effective compliance program designed to prevent and detect criminal antitrust violations.
FCS further agreed to a non-compete waiver aimed at increasing competition in the treatment of cancer patients in Southwest Florida. Under the agreement’s terms, FCS has agreed not to enforce any non-compete provisions with its current or former oncologists or other employees who, during the term of the DPA, open or join an oncology practice in Southwest Florida.
In announcing the resolution of the criminal charge against FCS, an Assistant Attorney General of the Department of Justice’s Antitrust Division stated, “Today’s resolution, with one of the largest independent oncology groups in the United States, is a significant step toward ensuring that cancer patients in Southwest Florida are afforded the benefits of competition for life-saving treatments. For almost two decades, FCS and its co-conspirators agreed to cheat by limiting treatment options available to cancer patients in order to line their pockets. The Antitrust Division is continuing its investigation to ensure that all responsible participants are held accountable to the maximum extent possible.”
If you have information regarding False Claims having been submitted to Medicare, Medicaid, TRICARE, other federal health care programs, or to other federal agencies/programs, and the information is not publically known and no actions have been taken by the government with regard to recovering the false claims, you should promptly consult with a False Claims Act attorney (also known as qui tam attorneys) in your U.S. state who may investigate the basis of your False Claims Act allegations and who may also assist you in bringing a qui tam lawsuit on behalf of the United States, if appropriate, for which you may be entitled to receive a portion of the recovery received by the U.S. government.
Click here to visit our website or call us toll-free in the United States at 800-295-3959 to be connected with qui tam lawyers (False Claims Act lawyers) in your U.S. state who may assist you with a False Claims Act lawsuit.
Turn to us when you don’t know where to turn.
The post Florida Oncology Group Admits To Antitrust Violations, Agrees To Pay $100 Million appeared first on Medical Malpractice Lawyers.